Helical closes $10M seed to turn bio foundation models into systems
📰 The Next Web AI
Helical raises $10M to develop bio foundation models into systems for pharma companies, leveraging AI for drug discovery
Action Steps
- Research how bio foundation models can be applied to pharma companies using AI
- Analyze the potential of Helical's technology in improving drug discovery processes
- Explore the use of AI in pharmaceutical research and development
- Evaluate the market potential of bio foundation models in the pharma industry
- Investigate the role of angel investors, such as Cohere and HuggingFace CEOs, in shaping the AI startup landscape
Who Needs to Know This
Data scientists and AI engineers at pharma companies can benefit from Helical's technology to improve drug discovery processes, while investors and entrepreneurs can learn from the startup's successful seed round
Key Insight
💡 Bio foundation models can be leveraged to improve drug discovery processes in pharma companies using AI
Share This
💡 Helical raises $10M to turn bio foundation models into systems for pharma companies! #AI #pharma #drugdiscovery
DeepCamp AI